Incidence and survival patterns of clear cell renal cell carcinoma from 2000 to 2017: A SEER Database Analysis

被引:0
|
作者
Zou, Sijue [2 ]
Cui, Liwen [1 ]
Pai, Pearl [1 ]
Lu, Yiping [1 ]
Li, Xiangyang [1 ]
Wang, Gang [1 ]
Huang, Wen [1 ]
Wang, Dan [3 ]
Shaikh, Nikhat [4 ,5 ]
Peng, Zhangzhe [2 ]
Peng, Zhuoming [6 ]
He, Haiyan [1 ]
Liao, Zhouning [1 ]
机构
[1] Univ Hong Kong, Shenzhen Hosp, Dept Nephrol, Shenzhen, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Nephrol, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Peoples R China
[4] Univ Med Ctr Hamburg Eppendorf, Dept Med, Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Translat Immunol, Hamburg, Germany
[6] Huazhong Univ Sci & Technol, Union Shenzhen Hosp, Dept Resp & Intens Care Med, Shenzhen 518000, Guangdong, Peoples R China
来源
JOURNAL OF CANCER | 2025年 / 16卷 / 05期
关键词
SEER; Clear cell renal cell carcinoma; Incidence; Age mortality;
D O I
10.7150/jca.105713
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Clear cell renal cell carcinoma (ccRCC) incidence and death have considerably changed in recent years. Our study aimed to investigate the incidence, survival, and tumor characteristics of ccRCC in the year of diagnosis. Methods: Our study participants were selected from the SEER database (2000-2017). Age-standardized incidence rates were calculated to compare incidence rates across time. In addition, we used Kaplan-Meier curves to calculate overall survival (OS) and Cox proportional hazards models to explore risk factors associated with mortality outcomes in patients with ccRCC. Results: In the SEER analysis from 2000 to 2017, the increasing trend in age-adjusted incidence of ccRCC has remained relatively stable over the years, increasing from 2.63 per 100,000 in 2000 to 8.79 per 100,000 in 2017. The increase in the incidence of patients at a localized stage plays a decisive role in the overall increase in the incidence of ccRCC. Conclusions: In the general population, patients diagnosed between 2009-2017 had a higher survival rate than those diagnosed between 2000-2008, which is consistent with all stages of the tumor. The incidence of ccRCC increases steadily with the year of diagnosis, while overall survival has significantly improved.
引用
收藏
页码:1591 / 1597
页数:7
相关论文
共 50 条
  • [31] Survival outcomes and patterns of utilization of cytoreductive nephrectomy in the tyrosine kinase inhibitors (TKO-era in metastatic clear cell renal cell carcinoma (ccRCC) and non-clear cell renal cell carcinoma (nccRCC): Analyses from the National Cancer Database (NCDB).
    Aragon-Ching, Jeanny B.
    Wang, Hongkun
    Trump, Donald L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] The impact of peptidase activity on clear cell renal cell carcinoma survival
    Larrinaga, Gorka
    Blanco, Lorena
    Sanz, Begona
    Perez, Itxaro
    Gil, Javier
    Unda, Miguel
    Andres, Leire
    Casis, Luis
    Lopez, Jose I.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2012, 303 (12) : F1584 - F1591
  • [33] Survival benefit of pancreatic metastasectomy of clear cell renal cell carcinoma
    Fang Yuan
    Tang Min
    Zhou WenTao
    Lou WenHui
    中华医学杂志英文版, 2019, 132 (22) : 2751 - 2752-2753
  • [34] RACIAL DIFFERENCES IN CLEAR CELL RENAL CELL CARCINOMA PRESENTATION AND SURVIVAL
    Williams, Heinric
    Ross, Ishai
    Popovic, Mihailo
    Posey, Zachary
    Powell, Isaac J.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 439 - 439
  • [35] Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma
    Ajadee, Alvira
    Mahmud, Sabkat
    Hossain, Md. Bayazid
    Ahmmed, Reaz
    Ali, Md. Ahad
    Reza, Md. Selim
    Sarker, Saroje Kumar
    Mollah, Md. Nurul Haque
    PLOS ONE, 2024, 19 (09):
  • [36] Influence of gene expression on survival of clear cell renal cell carcinoma
    Berglund, Anders
    Amankwah, Ernest K.
    Kim, Young-Chul
    Spiess, Philippe E.
    Sexton, Wade J.
    Manley, Brandon
    Park, Hyun Y.
    Wang, Liang
    Chahoud, Jad
    Chakrabarti, Ratna
    Yeo, Chang D.
    Luu, Hung N.
    Pietro, Giuliano D.
    Parker, Alexander
    Park, Jong Y.
    CANCER MEDICINE, 2020, 9 (22): : 8662 - 8675
  • [37] Survival benefit of pancreatic metastasectomy of clear cell renal cell carcinoma
    Fang, Yuan
    Tang, Min
    Zhou, Wen-Tao
    Lou, Wen-Hui
    CHINESE MEDICAL JOURNAL, 2019, 132 (22) : 2751 - 2753
  • [38] Selection of Optimal Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Clear Cell Renal Cell Carcinoma: A Predictive Model Based on SEER Database
    Zhang, Yishan
    Hu, Jintao
    Yang, Jingtian
    Xie, Yingwei
    Chen, Zhiliang
    Shangguan, Wentai
    Han, Jinli
    He, Wang
    Yang, Jingyin
    Zheng, Zaosong
    Zhong, Qiyu
    Zhu, Dingjun
    Xie, Wenlian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Trends in survival of ovarian clear cell carcinoma patients from 2000 to 2015
    Tian, Bing-Qian
    Wang, Shu-Wen
    Xu, Jing-Ying
    Wu, San-Gang
    Zhou, Juan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
    Ismail Selvi
    Umut Demirci
    Nazan Bozdogan
    Halil Basar
    International Urology and Nephrology, 2021, 53 : 1135 - 1138